ࡱ> npm 0bjbj11 8hSSH(fL L 848j(DDD.8080808080808$;=xT8DDT84i8###.8#.8##&2hb39UR2]-288082C>.C> b3b38C>3Dh#>TDDDT8T8"DDD8C>DDDDDDDDDL l: [INSERT ELECTRONIC Department Letterhead ON PAGE 1] Assent Form Template v. 2/01/2016 [Adolescents ages 13-17] The information highlighted in yellow is guidance. DELETE THIS AND ALL OTHER HIGHLIGHTED INSTRUCTIONS BEFORE SUBMITTING. RSRB Requirements: Use of Subject: The consent must use the term research subject rather than participant or volunteer. Use of 2nd Person: The assent form must be written in the 2nd person (e.g., You are being asked to take part in a research study about). Pagination: Maintain page numbering already inserted in the footer (e.g., 2 of 4). Version Date: Manually type the date in the footer, rather than selecting Insert Date from the toolbar to avoid automatic logo each time the document is opened. Margins: Maintain the bottom margin of at least 2 inches to provide space for watermarking upon approval. Sample Language: Sample language for certain types of procedures and risks (e.g., CT, MRI, X-ray, randomization, placebo, etc.) is included in the  HYPERLINK "http://www.rochester.edu/ohsp/rsrb/docTemplates/consentFormTemplates.html" Consent Document Sample Language guide. Assent Form [Insert Title of Study] Principal Investigator: [Insert] What are some general things you should know about research studies? You are being asked to take part in a research study. Your parent or guardian needs to give permission for you to be in this study. You do not have to be in this study if you dont want to, even if your parent has already given permission. You are free to choose whether or not to be in this study. You may decide not to join, or, if you join, you may decide to stop being in the study, at any time, for any reason, without penalty. What is the purpose of this study? logo is how we learn new things. The purpose of this research study is to learn aboutDescribe the general purpose of the study and include relevant background information. Be brief one or two words, preferably. You are being asked to be in the study because Specify condition, circumstances or other reason for recruitment. Note that this statement is OPTIONAL; if it does not make sense to tell subjects why they are being approached, this statement may be omitted. What will happen if you take part in the study? If you decide to take part in this study, you will be asked toDescribe what will be done or required of the research subject in lay terms. Be concise; avoid describing study procedures in lengthy narrative form. If there are multiple steps, use sub-headings, bullets, tables, pictures, etc. when appropriate. (If applicable for documenting study participation only in electronic health record) Your electronic health record will include information that you are in this study. This means that people who are allowed to see your electronic health record in the University of Rochester Medical Center, or other locations that are part of the medical center, will know that you participated in this research study. Also, the study team may be notified if you are seen for other health care services at this medical center or other locations that are part of the medical center. (If applicable for documenting study participation and test results in electronic health record) Your electronic health record will include information that you are in this study as well as results of tests done as part of this research. This means that people who are allowed to see your electronic health record in the University of Rochester Medical Center, or other locations that are part of the medical center, will know that you participated in this research study and may see the test results. Also, the study team may be notified if you are seen for other health care services at this medical center or other locations that are part of this medical center. Who will be told the things we learn about you in this study? Describe who will have access to the information collected. Be clear about whether pregnancy, illegal activity, psychological tendencies will be reported and to whom. Be clear about what parents and teachers will be told (e.g. The information we collect about you will be kept private. Only the people working on this study will be able to look at the information we collect. It will not affect how your doctor [or teacher, etc.] treats you.). How long will your part in this study last? Your participation in this study will lastIndicate the length of time of the individual subjects active involvement. If not previously stated in the procedures section, include the expected time needed for study visits/procedures as well as the overall length of time. What are the possible risks or discomforts involved from being in this study? ** The risks listed in the assent form should be consistent with what is stated in both the protocol and application.** Provide sufficient description of the risks to enable young subjects to decide if they want to participate. If appropriate, include information on probability of the risks and the magnitude and reversibility of harmful effects. The University of Rochester makes every effort to keep the information collected from you private. In order to do so, we will [insert protection measures]. Sometimes, however, researchers need to share information that may identify you with people that work for the University, the government or the study sponsor. If this does happen we will take precautions to protect the information you have provided. Results of the research may be presented at meetings or in publications, but your name will not be used. What are the possible benefits from being in this study? Choose or modify ONE of the following sentences as appropriate to the specific study: You will not benefit personally from being in this research study. - OR - You might not benefit from being in this research study. The potential benefit to you from being in this study might beList any direct benefits to the subject that might reasonably be expected from the research. **Payment to subjects for participation is not considered a benefit, it is an incentive. Payment information can be provided in the payment section below.** What if you or your parents dont want to be in this study? (If applicable) For biomedical research, use this section to discuss appropriate procedures or courses of treatment, if any that might be advantageous to the subject (e.g., standard treatment, no treatment, comfort care or participation in another study). For other types of research, use this section to discuss appropriate procedures or options, if any, that might be advantageous to the subject (e.g., not participating or alternative options). If the study is minimal risk and the only alternative is to not to participate this section is not necessary and should be deleted. Will you get any money or gifts for being in this study? Choose ONE of the following options, plus additional applicable language, as appropriate to the specific study: You will not be paid or given anything for participating in this study. -OR- You will be paid $XX for taking part in this study. If subjects are to be paid for participation, specify the amount, schedule of payment and conditions for payment (e.g., You will receive $100.00 for each completed study visit. You will not be paid for visits that you do not complete. You will be paid up to a total of $1200.00.). When applicable, payments should be based on a prorated system. If subjects will be given some token gift (e.g., a toy), instead of payment, describe in appropriate terms. What if you have questions about this study? For more information concerning this research or if you feel that being in the study has resulted in any research related injury, emotional or physical discomfort please contact: [insert contact persons name (for research related injury contact person must be a clinician and listed on first page of assent form)] at [telephone number] What if you have questions about your rights as a research subject? Please contact the University of Rochester logo Subjects Review Board at 265 Crittenden Blvd., CU 420628, logo NY 14642, Telephone (585) 276-0005 or (877) 449-4441 [insert country code (001) if applicable] for the following reasons: You wish to talk to someone other than the research staff about your rights as a research subject To voice concerns about the research To provide input concerning the research process In the event the study staff could not be reached Do I have to be in this study? Taking part in this research study is your choice. You are free not to take part or to withdraw at any time, for whatever reason. No matter what decision you make, there will be no penalty or loss of benefit to which you are otherwise entitled. In the event that you do withdraw from this study, the information you have already provided will be kept in a confidential manner. ** Insert any checkbox options for future use of biological specimens or research data, future contact, audio/video recording, etc. If possible, checkbox options & signature blocks should appear all on one page. Signature/Dates Subject Assent I have read (or have had read to me) the contents of this assent form and have been encouraged to ask questions. I have received answers to my questions. I agree to take part in this study. I have received (or will receive) a copy of this form for my records and future reference. ______________________________________ Print name if you agree to be in the study ______________________________________ _________________ Sign name if you agree to be in the study Date Person Obtaining Assent I have read this form to the subject and/or the subject has read this form. I will provide the subject with a copy of this assent form. An explanation of the research was given and questions from the subject were solicited and answered to the subjects satisfaction. In my judgment, the subject has demonstrated comprehension of the information. I have given the subject adequate opportunity to read the assent before signing. Name and Title (Print) Signature of Person Obtaining Assent Date     RSRB Case Number: 000XXXX Page  PAGE 5 of  NUMPAGES 5 Version Date: xx/xx/20xx 2367OSXYrȷ{eOeOeOe8- *hy0}he56;B*OJQJ^Jph* *hy0}hi&N56B*OJQJ^Jph* *hy0}he56B*OJQJ^Jph$ *hy0}56B*OJQJ^Jph$ *hj"56B*OJQJ^Jph* *hy0}hy0}56B*OJQJ^Jph! *h)t5B*OJQJ^Jph!hrOh)tB*OJQJ^Jph' *hrOh)t;B*OJQJ^Jph$ *hrOh)tB*OJQJ^Jph67Yr m P ` v w x  1$gdG5 $1$a$gdG5 & F1$gdj" & Fgdj"gdy0}gdG5$a$gdG5$a$gd)tm u w  E F L տiSi*B*OJQJ^Jph'hrOhe5>*B*OJQJ^Jph$ *hxhxB*OJQJ^Jphhx5B*OJQJ^Jph$hrOh85B*OJQJ^Jph!hrOh8B*OJQJ^Jph' *hxh85B*OJQJ^Jph' *hxhx5B*OJQJ^Jph'hrOhe56B*OJQJ^JphH T 13;FQ_h}̻ݪ̪wcPBhB*OJQJ^Jph$hrOh85B*OJQJ^Jph'hrOh85>*B*OJQJ^Jph!hrOhN5B*OJQJ^Jph!hrOhTB*OJQJ^Jph!hrOhKB*OJQJ^Jph!hrOh8B*OJQJ^Jph!hrOhB*OJQJ^Jph!hrOh' B*OJQJ^Jph!hrOhJB*OJQJ^Jph!hrOh*B*OJQJ^Jph %&{_`:*;gdG5 1$^gdtqgdtq 1$^gdG5gdG5 L1$]LgdG51$gdG59)*+Aۺ}jS;/ *hrOh86B*CJOJQJ^JaJph,hrOh9 6B*CJOJQJ^JaJph$hrOh85B*OJQJ^Jph'hrOh85>*B*OJQJ^Jph *hDOJQJ^J *hrOhGOJQJ^J *hrOhG6OJQJ^J!hrOh8B*OJQJ^Jph *hB*OJQJ^Jph$ *hrOh8B*OJQJ^Jph!hrOhGB*OJQJ^JphAIbiv #$%&zҺҺҺҊr]H: *htqhtqOJQJ^J) *htq6B*CJOJQJ^JaJph) *h86B*CJOJQJ^JaJph/ *hrOh'\n6B*CJOJQJ^JaJph/ *hrOhK6B*CJOJQJ^JaJph/ *hrOh*6B*CJOJQJ^JaJph/ *hrOh9 6B*CJOJQJ^JaJph/ *hrOh86B*CJOJQJ^JaJph) *hD6B*CJOJQJ^JaJphz`:ӻ{aIa{2,h[QNhea5B*CJOJQJ^JaJph/ *heahea5B*CJOJQJ^JaJph2 *h[QNhea56B*CJOJQJ^JaJph/ *h[QNhea5B*CJOJQJ^JaJph'h; hea5>*B*OJQJ^Jph'htqhea5>*B*OJQJ^Jph/ *htqhtq6B*CJOJQJ^JaJph#htqhtq6CJOJQJ^JaJ *htqhtqOJQJ^JhtqhtqOJQJ^J (*TU:;Ƕ{gTATAT0!hrOh8B*OJQJ^Jph$ *hrOha$B*OJQJ^Jph$ *hrOhsB*OJQJ^Jph'hrOhs5>*B*OJQJ^Jph'hrOha$5>*B*OJQJ^Jph'hrOh85>*B*OJQJ^Jph$ *hDh9 B*OJQJ^Jph!hDh9 B*OJQJ^Jph!hrOh9 B*OJQJ^Jph$hrOh9 5B*OJQJ^Jph'hrOh9 5>*B*OJQJ^Jph9?p  jJw(9<}}jVjEjE!hrOhI `B*OJQJ^Jph' *hrOhI `5B*OJQJ^Jph$ *hrOhI `B*OJQJ^Jph'hrOhI `5>*B*OJQJ^JphhWOJQJ^J *hjYghjYgOJQJ^Jh0hjYgOJQJ^JhjYgOJQJ^JhaGOJQJ^JhjYgB*OJQJ^Jph *hrOhOJQJ^J *hPOJQJ^J *hrOhsOJQJ^J(~= > ;"<""""j###%%%8'9'$a$gdG5gd)tgdG51$gdG58=Ans: < = y z y!!!!!!ӻӢ~scӻ~~~U~U~ *hhjYgOJQJ^JhrOhI `5>*OJQJ^J *hWOJQJ^J *hjYgOJQJ^J *hTOJQJ^J *hrOhTOJQJ^JhrOhI `6OJQJ^J *h|cOJQJ^J *hrOhI `OJQJ^Jh|cOJQJ^JhrOhI `OJQJ^J!hrOhI `B*OJQJ^Jphh|cB*OJQJ^Jph!!"8":";"<"""""""""""##i#ػn[M=M *hh)t5OJQJ^J *hh)tOJQJ^J$hrOhI `5B*OJQJ^Jph'hCqehI `5>*B*OJQJ^Jph'hCqeh5>*B*OJQJ^Jph!h5>*B*OJQJ^Jph'hrOhI `5>*B*OJQJ^JphhrOhI `OJQJ^J *hrOhI `5OJQJ^J *hrOhI `OJQJ^J *hjYgOJQJ^J *hhjYgOJQJ^Ji#j#######$$$$I%J%%%%%%ʺʪn]I6$hrOh85B*OJQJ^Jph'hrOh85>*B*OJQJ^Jph!hrOh8B*OJQJ^Jph$hrOh86B*OJQJ^Jph *hhOJQJ^J *hh9NOJQJ^J *hy0}OJQJ]^J *hh)tOJQJ]^J *hJbh)tOJQJ]^JhJbh)tOJQJ]^J *h-'h)tOJQJ]^Jh)tOJQJ]^JhJbh)tOJQJ^J%)&<&P&i&&&&!'%'7'8'9't'{'}''''''((+(,(mcVcVLVcV> *hh OJQJ^Jhj"OJQJ^Jhh OJQJ^Jh OJQJ^J'hrOhK5>*B*OJQJ^Jph'hrOh85>*B*OJQJ^Jph!hrOh8B*OJQJ^JphhrOhKOJQJ^J *h)OJQJ^J *hrOhKOJQJ^J!hrOhZiB*OJQJ^Jph!hrOh' B*OJQJ^Jph!hrOhh_B*OJQJ^Jph9'}'p(((()Z)[)z)**R+%,&,7,8,9,I,e-f--- 1$gdG5 $7$8$gdG5gdy0}gdG5$a$gdG5 & F @ 88^8gd gd 1$gdG5,(2(@(S(T(((Y)Z)[)x)y)z)))\*f****űxgxgxV?-hrOh B*OJPJQJ^JnHphtH!hrOh;B*OJQJ^Jph!hrOh' B*OJQJ^Jph!hrOh B*OJQJ^Jph'hrOhK5>*B*OJQJ^Jph'hrOh9N5>*B*OJQJ^Jph'hrOh 5>*B*OJQJ^JphhrOhKOJQJ^Jh]OJQJ^Jh OJQJ^J *hh OJQJ^J *h OJQJ^J**+>+++++#,$,%,&,',5,6,7,ɵɰ<+ hK7Ph 56>*CJ]aJhK7Ph,X5>*CJ]aJ hK7Ph 5;>*CJ]aJhK7Ph 5;>*CJaJhy0}5;>*CJaJ&hhy0}5>*B*CJ]aJph) *hhy0}5>*B*CJ]aJph) *hhy0}5>*B*CJ]aJph& *hhy0}5B*CJ]aJph& *hhy0}5B*CJ]aJphh)t5;>*CJaJh@OJQJ^JhrOh OJQJ^J7,8,9,G,I,,,e-x------------ʶudSudBd!hrOh9NB*OJQJ^Jph!hrOhftB*OJQJ^Jph!hrOhB*OJQJ^JphhB*OJQJ^Jph!hrOh8B*OJQJ^Jph!hrOh55B*OJQJ^Jph!hrOhY"B*OJQJ^Jph'hrOh85>*B*OJQJ^Jph'hrOhY"5>*B*OJQJ^Jph'hrOh 5>*B*OJQJ^JphhrOhB05CJ]aJ---%.&.>./// 000H0J0K0M0N0P0Q0S0T000gde 1$7$8$H$gdG5$a$gdG5gdG5^gdG51$gdG5 1$gdG5--..%.&.>.n.u.v.////0 0 0ݴyfUG:0:h)OJQJ^JhrOh OJQJ^JhrOh >*OJQJ^J!hrOh\i?B*OJQJ^Jph$hrOhY"6B*OJQJ^Jph$hrOhY"B*OJQJ]^Jph!hrOhY"B*OJQJ^Jph,hrOhY"56>*B*OJQJ\]ph)hrOhY"56B*OJQJ\]ph'hrOhhB*OJQJ^Jph!hrOhB*OJQJ^Jph!hrOh|B*OJQJ^Jph 00000G0H0I0K0L0N0O0Q0R0T0Y0Z0^0_0i0m0s0t0z0{0|0}000000000000ƾttatttat%h&|yCJOJQJ^JaJmHnHu)jhrOhtqCJOJQJU^JaJ# *hrOhtqCJOJQJ^JaJhtqCJOJQJ^JaJ hrOhtqCJOJQJ^JaJhxf jhxf UhrOhY"OJQJ^JhrOh OJQJ\^JhrOh >*OJQJ\^JhrOh 5OJQJ^J%0000$a$gdG50000hrOhY"OJQJ^Jhxf htq6&P1h:p&|y/ =!"#$@ % DyK yK http://www.rochester.edu/ohsp/rsrb/docTemplates/consentFormTemplates.htmlyX;H,]ą'c^ 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH @`@ 8NormalCJ_HaJmH sH tH Z@Z   Heading 1$<@&5CJ KH OJQJ\^JaJ R@R ea Heading 3$<@&5CJOJQJ\aJN@N Y" Heading 5$h@&^h6OJQJ\^JDA D Default Paragraph FontRiR  Table Normal4 l4a (k (No List 2O2 8toa  (#$aJTR@T 8Body Text Indent 2 ^ 6CJaJ4 @4 8Footer  !6U`!6 8 Hyperlink >*B*ph2B22 8 Body Textx4B4 8Header  !H@RH Ux Balloon TextCJOJQJ^JaJhObh  consent text $7$8$CJOJQJ^JaJmH sH *q*  header-a1*W`* Strong5\B'`B nYComment ReferenceCJaJ<@< nY Comment TextCJaJ@j@@ nYComment Subject5\ZoZ eaHeading 3 Char&5CJOJQJ\_HaJmH sH tH FV`F sbFollowedHyperlink >*B* phPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] (h eeehL H Az!i#%,(*7,- 000!"#$%'()*,-.013 9'-00 &+/2Lm(X+249DFh!@ @H 0(  0(  B S  ? ssssssssss"( "( :*urn:schemas-microsoft-com:office:smarttagsStreet= *urn:schemas-microsoft-com:office:smarttags PlaceType=*urn:schemas-microsoft-com:office:smarttags PlaceName>*urn:schemas-microsoft-com:office:smarttags PersonName;*urn:schemas-microsoft-com:office:smarttagsaddress9 *urn:schemas-microsoft-com:office:smarttagsplace9*urn:schemas-microsoft-com:office:smarttagsState ȗl  nou;;G(H(J(K(M(N(P(Q(S(T(s(}(((((OQ- / O9;gjH(J(K(M(N(P(Q(S(T(((33333333r>>Pl_`rx$ UU;;9?8=ns:I88tt}Y!Z!Z![![!""*#>#R#&$6$6$8$8$9$9$G$G$%%%%%%%%%%%% & &%&%&''G(H(H(J(K(K(M(N(P(Q(S(T(Y(_(((r>>Pl_`rx$ ;;I '!'!Y!Y!R#&$8$8$9$9$G(H(H(J(K(K(M(N(P(Q(S(T(((J2zsR~4h]Dv~6Erz_pm?ut!dh^`OJQJo(hHh  ^ `OJQJo(hHh  ^ `OJQJo(hHhxx^x`OJQJo(hHhHH^H`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhhh^h`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHhpp^p`OJQJo(hHh@ @ ^@ `OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hH @ @ ^@ `CJOJQJo(hH ^`OJQJ^Jo(hHo pp^p`OJQJo(hH @ @ ^@ `OJQJo(hH ^`OJQJ^Jo(hHo ^`OJQJo(hH ^`OJQJo(hH ^`OJQJ^Jo(hHo PP^P`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJQJo(hHhpp^p`OJQJ^Jo(hHoh@ @ ^@ `OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHhPP^P`OJQJ^Jo(hHoh  ^ `OJQJo(hHJ24h]D?ut_pv~6E                SL                          pn7S(1od3s/o"| R#R_' xf R ]I sH e]5-gc*_n:WPI#*k T{#0JG7ey"Y"j"z"#%4#?#$&%'J'(" ((0(y()?)*B*g*Vz-B0F0J13555:5G5Cu5Q6d8J9;S=&S=E8>8?Gb?\i?@@~MAZA?B )BEE9G3G~G[XH&I`eIVJKkLpLi&N3NzNO*OrOK7PnPn7QRM7TW,XnYN&ZT_h_I `D%`easbCqeF[fjYg9hZi/jPjwl'\n.oToqgqs sWJsftttx3xUxWYx&|yzz#|{Ak|y0} ]},h~q:QF|DD 8WM|cBaib|{2T W7oT%F8yGfU59N"aGl ^IZ& a$!j\E9 M+;A`6>dJYd!E& ^}]N57"(7!'9[M"s 1'mD| dOgike,;uDtq)t95Vg-!Z~g;O^-r>Gf7D+<?z-e7 5GKf"tGG]?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\^_`abcdfghijkloRoot Entry F`cR2]qData 51Table=c>WordDocument8hSummaryInformation(]DocumentSummaryInformation8eCompObjr  F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q